Journal
VETERINARY PATHOLOGY
Volume 59, Issue 2, Pages 236-243Publisher
SAGE PUBLICATIONS INC
DOI: 10.1177/03009858211062636
Keywords
CPA3; dog; immunohistochemistry; intestine; liver; mast cell tumor; mastocytoma; skin; spleen
Categories
Funding
- Finnish Veterinary Foundation
Ask authors/readers for more resources
This study investigates the expression of CPA3 in different tissues and tumor cells in dogs, showing three distinct labeling patterns in MCTs. CPA3 is proposed as a novel immunohistochemical marker for canine mast cells in both health and disease.
Mast cell tumors (MCTs) are one of the most common cutaneous malignancies in dogs. Previous studies have reported expression of mast cell-specific proteases chymase and tryptase in canine cutaneous MCTs and in connective tissue and mucosal mast cells. In humans and rodents, mast cells express an additional specific protease, carboxypeptidase A3 (CPA3). In this article, we describe CPA3 immunoreactivity in connective tissue, visceral, mucosal, and neoplastic mast cells in dogs. Positive immunolabeling for CPA3 was observed in nonneoplastic mast cells in 20/20 formalin-fixed paraffin-embedded normal tissues (skin, liver, spleen, intestine), and in 63/63 MCTs irrespective of their histological grade. CPA3 protein expression was comparable to that of c-kit in both the nonneoplastic and neoplastic mast cells. Three distinct labeling patterns (membranous, diffuse, and focal cytoplasmic) were observed for CPA3 in MCTs. The focal cytoplasmic labeling pattern was associated with high-grade MCTs staged with the Kiupel 2-tier grading criteria. We propose CPA3 as a novel immunohistochemical marker for canine mast cells in health and disease.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available